ArticleDigestive diseases and sciences2017

Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.

Jessica R Allegretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.